Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism OGG1 inhibitors(8-oxoguanine DNA glycosylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H18BrIN4O2 |
InChIKeyFZLKVWWPFOLPKF-UHFFFAOYSA-N |
CAS Registry2304947-71-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | SE | 16 Nov 2018 |